SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Thomas Haegin who wrote (823)1/24/1998 6:36:00 PM
From: Premier  Read Replies (1) of 2068
 
Saw a pharmacist client yesterday. He indicated an increase in new patients ( based on increase in prescriptions at his pharmacy, an unscientific statistic) from Oxford and decrease in prescriptions from Aetna patients. This was a crude determination at one pharmacy on long island. The pharmacist also metioned that a patient did not have palstic card but he presented an enrollment number given by Oxford. The pharmacist could punch in the number in his computer and was comfortable in filling the prescription. In a similar situation six months ago the pharmacist would have asked for payment from the patient. This leads me to believe that Oxford is working reasonably hard in putting its house in order.

I cannot say that Oxford stock will reverse its course tomorrow but talks of its death are premature.

Premier
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News